Hetero Healthcare and Enzene Biosciences have introduced Perzea to expand affordable access to pertuzumab therapy for HER2+ breast cancer, leveraging EnzeneX™ technology.
Thursday, February 5
Trending
- What Age Limits Apply in Travel Insurance for Senior Citizens
- BGMI Players Can Unlock New Outfit via Latest Redeem Code for February 4th
- Jashn Realty Announces Rs. 3,200 Crore Strategic Investment Plan and Accelerated Delivery Focus at Lucknow Press Conference
- Ducon’s Early Carbon Capture Strategy Receives Policy Validation as India Accelerates CCUS Deployment
- 5 Years. 5 Products. One Mission: ENORD Marks Half a Decade of Indigenous AI-Driven Drone Innovation on Drone Day 2026
- Big Boost for Para Sports: Yogesh Shelly Appointed Director of Para Athlete Development and Special Programs, India Para Powerlifting; Office Inaugurated by JP Singh and Satya Prakash Sangwan
- Davaindia Launches 77 New Company Stores on India’s 77th Republic Day, Strengthening Its Mission of Affordable Healthcare
- Airports Authority of India Awards INR 17.16 Crore AI-Powered BIM-Based Project Monitoring System Contract to SoftTech Engineers Limited
